14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $60.86 $75.66 Wednesday, 1st May 2024 CYTK stock ended at $63.37. This is 3.34% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 4.70% from a day low at $61.37 to a day high of $64.26.
90 days $60.86 $84.05
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
Jun 16, 2020 $22.20 $22.64 $21.31 $22.31 514 566
Jun 15, 2020 $20.84 $22.06 $20.80 $21.73 768 002
Jun 12, 2020 $21.10 $21.38 $20.20 $21.38 614 055
Jun 11, 2020 $21.30 $22.05 $20.67 $20.95 1 318 186
Jun 10, 2020 $21.19 $21.81 $20.88 $21.71 1 032 462
Jun 09, 2020 $20.99 $21.54 $20.76 $21.05 598 145
Jun 08, 2020 $20.33 $21.14 $20.02 $21.11 482 620
Jun 05, 2020 $20.24 $20.63 $19.32 $20.24 429 708
Jun 04, 2020 $20.40 $20.96 $19.94 $20.04 400 430
Jun 03, 2020 $21.08 $21.09 $20.38 $20.60 397 243
Jun 02, 2020 $20.88 $21.63 $20.35 $21.11 469 501
Jun 01, 2020 $20.49 $21.36 $20.43 $20.90 447 787
May 29, 2020 $20.73 $20.79 $19.67 $20.71 1 249 948
May 28, 2020 $21.38 $21.91 $20.69 $20.72 418 173
May 27, 2020 $21.92 $21.94 $20.26 $21.24 621 398
May 26, 2020 $22.36 $22.88 $21.85 $21.90 781 550
May 22, 2020 $21.50 $21.94 $21.02 $21.91 437 502
May 21, 2020 $21.81 $21.92 $20.87 $21.61 461 430
May 20, 2020 $21.28 $22.47 $21.01 $21.82 483 463
May 19, 2020 $21.87 $22.20 $20.90 $20.93 596 949
May 18, 2020 $22.10 $23.04 $21.86 $22.22 702 599
May 15, 2020 $21.13 $21.75 $20.70 $21.64 1 262 305
May 14, 2020 $21.26 $21.61 $20.46 $21.24 798 652
May 13, 2020 $21.06 $21.93 $20.50 $21.61 2 123 458
May 12, 2020 $20.95 $22.99 $20.81 $20.96 1 874 654
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT